Ensure successful and timely market access strategies for Sobi’s pipeline and launch products in Germany with a focus on integrated access planning, policy shaping, and sustainable patient access.
Independently manage and coordinate AMNOG processes including dossier preparation, G-BA benefit assessments, and price negotiations with the GKV-SV.
Develop and implement dossier and negotiation strategies in close collaboration with cross-functional teams (Medical, HEOR, Regulatory, Marketing).
Prepare and lead (early) G-BA consultations, written statements, and oral hearings.
Analyze the German pricing, reimbursement, and health policy environment including competitive intelligence, to derive strategic recommendations for pipeline and launch products.
Develop pricing strategies and business cases considering clinical value, competitive landscape, and health policy framework, ensuring alignment with senior management.
Shape and articulate value propositions and health economic arguments to support pricing, reimbursement, and negotiations strategies.
Closely align with global and regional Market Access, Medical, and Commercial teams to ensure consistent strategies.
Contribute to the continuous improvement of Market Access excellence within the DACH team through best practice sharing and process optimization.
Build and maintain relationships with key external stakeholders (e.g., G-BA, GKV-SV, scientific associations, patient advocacy groups).
Select, manage, and guide external agencies and consultants, building trust-based partnerships to ensure high-quality deliverables, effective collaboration, and alignment with Sobi’s strategic Market Access objectives.
Support the development of stakeholder engagement plans in the context of AMNOG and pricing negotiations.
Continuously monitor and analyze the health policy and AMNOG regulatory environment, assess potential impacts on Sobi’s portfolio, and proactively inform strategic decision-making.
Evaluate clinical development programs to anticipate and shape future market access and evidence requirements in Germany and EU (EU-HTA).
Requirements
University degree (health) economics, pharmaceutical, health care management, natural science (biochemistry, biology…) or similar
5 to 8 years of biotech/pharmaceutical/consulting experience in a reimbursement/market access related role
Experiences in medical writing, ideally in the market access area, ideally combined with experiences in clinical data design and interpretation, HTA, epidemiology and statistic
Deep knowledge of the market access environment and health care system in Germany, specifically AMNOG regulation and reimbursement pathways
Ability to work in cross-functional teams under time pressure and with senior management attention
Very good communication skills (oral and writing) in both German and English and experienced in communicating complex information to target groups or local and Global management
Strong skills in Microsoft office, especially Excel and Powerpoint, and presentations
Rigorous, organized and respecting timelines and deadlines along with flexibility in changing priorities
Strong analytical and project/team management skills, innovative thinking and problem solving skills
“Can do” attitude, Team player, Willingness to accept responsibility, Sense of duty and urgency
Ability to work independently and as part of a wider multi-disciplinary team
The ideal candidate also brings: Advanced biostatistical understanding and experience, Continuous improvement mind set and Knowledge in EU-HTA